The low basal expression of APOL1 in tumor cells may already be sufficient to fulfill its oncogenic functions, while the downregulation of APOL1 in tumor cells could be a strategy employed by cancer cells to achieve immune evasion. The gene discussed is APOL1; the disease is neoplasm.